Treatment of Developmental Dysplasia of the HIp

NCT03193385 | Unknown

• 1 other identifier: DDH
• Study Type: observational
• Target: 20
• Locations: 0 countries
• Sites: N/A

Brief Summary

Closed reduction is where the thigh bone is placed into the socket without any surgical incision being made. This is more likely to be performed in a child under the age of four year. The femoral head is gently manipulated into the socket, whilst the child is under anaesthetic. Once the femoral head is in place, a hip Spica is applied and can remain in place for up to three months to maintain the hip in the correct position. This allows time for healing and for the socket and the thigh bone to mould together as a joint. The purpose of this study was to identify and evaluate risk factors of avascular necrosis (AVN) after closed treatment for developmental dysplasia of the hip (DDH). assessed according to Salter's classification system.

Conditions

Hip Dysplasia

Outcome Measures

Primary Outcomes (1)

• Harris Hip score

  harris hip score for function of the hip

  6 month

Study Arms (1)

Closed reduction

Procedure: closed reduction

Interventions

closed reduction PROCEDURE

Closed reduction is where the thigh bone is placed into the socket without any surgical incision being made. This is more likely to be performed in a child under the age of four year. The femoral head is gently manipulated into the socket, whilst the child is under anaesthetic. Once the femoral head is in place, a hip Spica is applied and can remain in place for up to three months to maintain the hip in the correct position. This allows time for healing and for the socket and the thigh bone to mould together as a joint.

Closed reduction

Eligibility Criteria

• Age: 6 Months - 4 Years
• Sex: all
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

closed reduction of the neglected hip dyplasia The purpose of this study to identify predictive factors that would best indicate the satisfactory function and radiological outcome after close redaction of developmentlal dysplasia of the hip in children

You may qualify if:

• Children that missed the initial diagnosis after birth and presented around six months up to four years which included in this study. All patients did not receive prior treatment such as Pavlik harness or splints.

You may not qualify if:

• Patients with neurological, septic, traumatic or syndromatic dislocation is not included in our study.

Sponsors & Collaborators

• Assiut University: lead

Related Publications (5)

• Anuar R, Mohd-Hisyamudin HP, Ahmad MH, Zulkiflee O. The Economic Impact of Managing Late Presentation of Developmental Dysplasia of Hip (DDH). Malays Orthop J. 2015 Nov;9(3):40-43. doi: 10.5704/MOJ.1511.006.

  PMID: 28611908 BACKGROUND

• de Hundt M, Vlemmix F, Bais JM, Hutton EK, de Groot CJ, Mol BW, Kok M. Risk factors for developmental dysplasia of the hip: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2012 Nov;165(1):8-17. doi: 10.1016/j.ejogrb.2012.06.030. Epub 2012 Jul 21.

  PMID: 22824571 BACKGROUND

• Brady RJ, Dean JB, Skinner TM, Gross MT. Limb length inequality: clinical implications for assessment and intervention. J Orthop Sports Phys Ther. 2003 May;33(5):221-34. doi: 10.2519/jospt.2003.33.5.221.

  PMID: 12774997 BACKGROUND

• Sarkissian EJ, Sankar WN, Baldwin K, Flynn JM. Is there a predilection for breech infants to demonstrate spontaneous stabilization of DDH instability? J Pediatr Orthop. 2014 Jul-Aug;34(5):509-13. doi: 10.1097/BPO.0000000000000134.

  PMID: 24590335 BACKGROUND

• Race C, Herring JA. Congenital dislocation of the hip: an evaluation of closed reduction. J Pediatr Orthop. 1983 May;3(2):166-72. doi: 10.1097/01241398-198305000-00004.

  PMID: 6863522 BACKGROUND

MeSH Terms

Conditions

Hip Dislocation

Interventions

Closed Fracture Reduction

Condition Hierarchy (Ancestors)

Joint Dislocations; Joint Diseases; Musculoskeletal Diseases; Wounds and Injuries; Hip Injuries

Intervention Hierarchy (Ancestors)

Fracture Fixation; Orthopedic Procedures; Therapeutics

Central Study Contacts

abdel-khalek Hafez ibrahim, MD

CONTACT

0201222302088; ortho2015@yahoo.com

Nariman aboloyoun, MD

CONTACT

0201222302343; Aboloyoun@yahoo.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: June 16, 2017
• First Posted: June 20, 2017
• Study Start: July 1, 2017
• Primary Completion: July 1, 2019
• Study Completion: July 1, 2020
• Last Updated: June 20, 2017

Record last verified: 2017-06

Data Sharing

• IPD Sharing: Will not share